Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial

Gazzard, Gus; Konstantakopoulou, Evgenia; F. Garway‐Heath, David; Garg, Anurag; Vickerstaff, Victoria; Hunter, Rachael; Ambler, Gareth; Bunce, Catey; Wormald, Richard; Nathwani, Neil; Barton, Keith; S. Rubin, Gary; Buszewicz, Marta; Ambler, Gareth; Barton, Keith; Bourne, Rupert; C. Broadway, David; Bunce, Catey; Buszewicz, Marta; Davis, Amanda; Garg, Anurag; F. Garway‐Heath, David; Gazzard, Gus; Hunter, Rachael; Jayaram, Hari; Jiang, Yuzhen; Konstantakopoulou, Evgenia; Yang Lim, Sheng; Liput, Joanna; D Manners, T; Morris, Stephen; Nathwani, Neil; S. Rubin, Gary; G. Strouthidis, Nicholas; Vickerstaff, Victoria; Wilson, Sarah; Wormald, Richard; Zhu, Haogang

doi:10.1016/s0140-6736(18)32213-x

Public

Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial

Published in The Lancet • Mar 9, 2019

Authors:

Gus Gazzard

Evgenia Konstantakopoulou

David F. Garway‐Heath

Abstract

BACKGROUND: Primary open angle glaucoma and ocular hypertension are habitually treated with eye drops that lower intraocular pressure. Selective laser trabeculoplasty is a safe alternative but is rarely used as first-line treatment. We compared the two. METHODS: In this observer-masked, randomised c...

Subject

Medicine

Intraocular pressure

Glaucoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!